Do You Need Blood Tests Before or During Weight-Loss Treatment?

Prescription weight-loss treatment does not come with one universal blood-test checklist. Some people may need blood tests before treatment, during treatment, or both; others may not need the same investigations at all.

What is useful depends on your medical history, symptoms, current medicines, weight-related health conditions and the treatment being considered. The purpose of testing is to answer a clinical question - for example, whether blood sugar, kidney, liver, cholesterol or thyroid results could affect the treatment plan - rather than to order the broadest possible panel by default.

This guide focuses on blood testing around prescription weight-management treatment. It does not compare Mounjaro and Wegovy in detail, explain doses or side effects, or replace the individual medicine and Weight Management pages.

Blood tests can provide useful baseline information when a clinician needs to understand a health condition that may affect treatment choice, follow-up or the wider weight-management plan.

For example, testing may help identify previously unrecognised high blood sugar, provide information about kidney or liver function, clarify cardiovascular risk factors such as cholesterol, or investigate symptoms that could suggest thyroid dysfunction. The reason for testing should come from the clinical assessment rather than from a rule that everyone using weight-loss medication needs the same panel.

Blood results are only one part of suitability. A clinician also needs your medical history, current medicines, previous treatment, weight and BMI where relevant, pregnancy plans, symptoms and any conditions that could alter the benefits or risks of treatment.

The exact tests depend on the question being asked, but common areas that may be considered include blood sugar, kidney function, liver function, cholesterol and triglycerides, and thyroid function.

This does not mean every person needs every test. A result is most useful when it can change or clarify the next decision. For information about available blood tests and what each includes, explore LIVVE’s blood-testing service.

No. There is no single blood-test panel that is appropriate for every person starting or using prescription weight-loss treatment.

Someone with type 2 diabetes or raised blood sugar may need a different approach from someone without diabetes. A person with known kidney or liver disease may need closer review of those areas. Someone with marked fatigue, palpitations or unexplained weight change may need targeted assessment for another condition rather than a routine weight-management panel.

The same principle applies during treatment: repeat testing should be driven by clinical need, existing conditions, symptoms, medicines and the result of previous tests rather than by a universal calendar.

Glucose and HbA1c provide information about blood-sugar regulation. They may identify diabetes or prediabetes, show how well known diabetes is controlled, or provide a useful baseline when treatment may influence appetite, weight and glucose levels.

If you already use medicines for diabetes, changes in food intake, weight and glucose control may affect how the wider diabetes plan needs to be reviewed. That review is particularly important if medicines that can cause low blood sugar are involved.

An abnormal HbA1c or glucose result does not automatically mean weight-loss treatment cannot be used. It may mean the clinician needs to understand the result, coordinate care or adjust the wider treatment plan before deciding what is appropriate.

Kidney and liver results can provide useful context when there is known disease, a relevant medical history, symptoms, or another clinical reason to check them before treatment.

Kidney function can also become important during treatment if repeated vomiting or diarrhoea causes dehydration. GLP-1-based medicines can cause gastrointestinal symptoms in some people, and significant fluid loss can place additional strain on kidney function. This is one reason persistent vomiting, diarrhoea or difficulty keeping fluids down should be reviewed rather than treated as something to simply tolerate.

Liver tests may be useful where there is known liver disease, abnormal previous results or other risk factors. The purpose is not to prove that treatment is safe from one blood result, but to make sure relevant health information is included in the prescribing decision.

Cholesterol and triglyceride results may form part of a broader assessment of cardiovascular and metabolic health. They can help identify risk that deserves attention alongside weight management rather than being used simply as a pass-or-fail test for medication.

For some people, improving weight is only one part of the health goal. Blood pressure, blood sugar, lipids, sleep, mobility and other risk factors may all matter. A clinically useful review looks at that wider picture instead of judging progress from the scales alone.

Thyroid problems can contribute to symptoms such as fatigue, changes in weight, palpitations, temperature intolerance and changes in bowel habit. If the history suggests thyroid dysfunction may be contributing, a thyroid function test can help answer that separate question.

Thyroid testing is not an automatic requirement simply because someone has gained weight. It is most useful when symptoms or history make thyroid disease a realistic possibility. If you want more detail about symptom overlap, read Thyroid or Menopause? How to Tell the Difference.

Not necessarily. There is no single repeat-testing schedule that applies to everyone using prescription weight-loss treatment.

Repeat tests may be useful if a baseline result was abnormal, if there is diabetes or another condition that needs monitoring, if symptoms raise a new concern, if dehydration or another complication is suspected, or if the clinician wants to see whether a previously identified health marker has changed.

Routine clinical review still matters even when blood tests are not needed. Weight trend, appetite, food intake, hydration, side effects, medicines, blood pressure where relevant and overall wellbeing can all affect the plan. Detailed dose changes, side-effect management and treatment progression are covered in the weight-loss hub and product pages rather than here.

An abnormal result does not automatically mean treatment must stop or cannot begin. The next step depends on which result is abnormal, how significant the change is, whether it is new, your symptoms, medicines and medical history.

A clinician may repeat the test, request more targeted investigations, ask your GP or specialist to review the result, or decide that another health issue should be addressed before or alongside weight-loss treatment.

Some results need more urgent follow-up than others. If a blood test identifies a potentially significant abnormality, it should be assessed on its own clinical merits rather than interpreted only through the lens of weight loss.

LIVVE starts with a clinical assessment to understand your health history, current medicines, symptoms, previous results and treatment goals. Whether you’re considering weight-loss injections or tablets, your clinician can recommend blood tests where they may provide useful information to support personalised care.

If testing is recommended, you can explore LIVVE’s blood-testing service to understand the available options and how testing is arranged. You can also explore our weight-management treatments, including injections and tablets, to learn more about the available medicines and how to access treatment.

The aim is targeted testing with a clear purpose - not testing for testing's sake.

Contact LIVVE if you are unsure whether a symptom or new health issue needs review during treatment, particularly if you have persistent vomiting or diarrhoea, difficulty keeping fluids down, marked weakness or dizziness, or a significant change in a condition such as diabetes.

Seek urgent medical help for severe or persistent abdominal pain, chest pain, severe shortness of breath, fainting, severe dehydration, confusion, or another possible medical emergency. Do not wait for a routine blood test or scheduled weight-management review if you are seriously unwell.